Patents by Inventor Amiya Prasad Bhaduri

Amiya Prasad Bhaduri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination kit used in the treatment of malaria
    Patent number: 7404962
    Abstract: A combination kit for the treatment of malaria caused by Plasmodium vivax (P. vivax) having individual doses of an anti-malarial agent, 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I) in the form of capsules; individual doses of the anti-malarial agent, chloroquine in the form of tablets; and instruction material for the administration of the two anti-malarial drugs. The combination kit is particularly suited for a 6 days treatment regimen where the treatment is rendered by five tablets containing 500 mg of chloroquine phosphate (equivalent to 300 mg base), three to be taken on day one and one each on days two and three; and five capsules containing 25 mg of 3-[1-[[4-[(6-methoxy-8-quinolinyl)amino]pentyl]amino]ethylidene]-dihydro-2(3H)-furanone (I), one each to be taken on days two to six.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: July 29, 2008
    Assignees: Nicholas Piramal India Limited, Council of Scientific and Industrial Research
    Inventors: Francis Joseph Pinto, Swati Ajay Piramal, Ram Pratap, Amiya Prasad Bhaduri, Harsh Pati Thapliyal, Sunil Kumar Puri, Guru Prasad Dutta, Anil Kumar Dwivedi, Satyawan Singh, Pratima Srivastava, Vikash Chandra Pandey, Sudhir Srivastava, Shio Kumar Singh, Ram Chandra Gupta, Jagdishwar Sahai Srivastava, Omkar Prasad Asthana
  • Method for the treatment of malaria by the use of primaquine derivative N-(3-ethylidinotetrahydrofuran-2-one)-N- (6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent
    Patent number: 7183291
    Abstract: The present invention a novel use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine in the treatment and controlling the spread of malaria. In particular, the present invention discloses a method of treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as a gametocytocidal agent.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: February 27, 2007
    Assignee: Council of Scientific and Industrial Research
    Inventors: Ram Pratap, Amiya Prasad Bhaduri, Harsh Pati Thapliyal, Sunil Kumar Puri, Guru Prasad Dutta, Anil Kumar Dwivedi, Satyawan Singh, Pratima Srivastava, Vikash Chandra Pandey, Sudhir Srivastava, Shio Kumar Singh, Ram Chandra Gupta, Jagdishwar Sahai Srivastava, Omkar Prasad Asthana
  • METHOD FOR THE TREATMENT OF MALARIA BY THE USE OF PRIMAQUINE DERIVATIVE N1-(3-ETHYLIDINOTETRAHYDROFURAN-2-ONE) -N 4-(6-METHOXY-8-QUINOLINYL)-1,4-PENTANEDIAMINE AS GAMETOCYTOCIDAL AGENT
    Publication number: 20030199697
    Abstract: The present invention a novel use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine in the treatment and contolling the spread of malaria. In particular, the present invention discloses a method of treatment of malaria by the use of primaquine derivative N1-(3-ethylidinotetrahydrofuran-2-one)-N4-(6-methoxy-8-quinolinyl)-1,4-pentanediamine as a gametocytocidal agent.
    Type: Application
    Filed: May 21, 1999
    Publication date: October 23, 2003
    Inventors: RAM PRATAP, AMIYA PRASAD BHADURI, HARSH PATI THAPLIYAL, SUNIL KUMAR PURI, GURU PRASAD DUTTA, ANIL KUMAR DWIVEDI, SATYAWAN SINGH, PRATIMA SRIVASTAVA, VIKASH CHANDRA PANDEY, SUDHIR SRIVASTAVA, SHIO KUMAR SINGH, RAM CHANDRA GUPTA, JAGDISHWAR SAHAI SRIVASTAVA, OMKAR PRASAD ASTHANA